Atlas Capital Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,910
| Closed | -$263K | – | 1105 |
|
|
2026
Q1 | $263K | Hold |
2,910
| – | – | 0.03% | 371 |
|
|
2025
Q4 | $262K | Buy |
+2,910
| New | +$276K | 0.03% | 364 |
|
|
2025
Q2 | $288K | Hold |
3,160
| – | – | 0.04% | 341 |
|
|
2025
Q1 | $358K | Sell |
3,160
-966
| -23% | -$103K | 0.04% | 309 |
|
|
2024
Q4 | $436K | Buy |
4,126
+3,960
| +2,386% | +$425K | 0.06% | 270 |
|
|
2024
Q3 | $17.9K | Sell |
166
-3,960
| -96% | -$432K | ﹤0.01% | 684 |
|
|
2024
Q2 | $448K | Buy |
4,126
+3,960
| +2,386% | +$467K | 0.06% | 242 |
|
|
2024
Q1 | $21.9K | Sell |
166
-4,072
| -96% | -$509K | ﹤0.01% | 656 |
|
|
2023
Q4 | $516K | Sell |
4,238
-61
| -1% | -$6.81K | 0.07% | 220 |
|
|
2023
Q3 | $482K | Hold |
4,299
| – | – | 0.08% | 195 |
|
|
2023
Q2 | $626K | Hold |
4,299
| – | – | 0.09% | 164 |
|
|
2023
Q1 | $555K | Hold |
4,299
| – | – | 0.09% | 172 |
|
|
2022
Q4 | $548K | Hold |
4,299
| – | – | 0.09% | 177 |
|
|
2022
Q3 | $449K | Hold |
4,299
| – | – | 0.08% | 199 |
|
|
2022
Q2 | $452K | Sell |
4,299
-4,182
| -49% | -$496K | 0.08% | 215 |
|
|
2022
Q1 | $1.08M | Buy |
8,481
+2,463
| +41% | +$297K | 0.17% | 109 |
|
|
2021
Q4 | $742K | Sell |
6,018
-2,539
| -30% | -$332K | 0.11% | 157 |
|
|
2021
Q3 | $1.22M | Sell |
8,557
-206
| -2% | -$30.3K | 0.2% | 98 |
|
|
2021
Q2 | $1.37M | Buy |
8,763
+16
| +0.2% | +$2.59K | 0.23% | 92 |
|
|
2021
Q1 | $1.36M | Hold |
8,747
| – | – | 0.26% | 83 |
|
|
2020
Q4 | $1.31M | Sell |
8,747
-3,126
| -26% | -$442K | 0.28% | 77 |
|
|
2020
Q3 | $1.57M | Sell |
11,873
-325
| -3% | -$42.5K | 0.37% | 58 |
|
|
2020
Q2 | $1.41M | Sell |
12,198
-197
| -2% | -$22.7K | 0.33% | 69 |
|
|
2020
Q1 | $1.22M | Buy |
12,395
+8,275
| +201% | +$1.08M | 0.36% | 70 |
|
|
2019
Q4 | $599K | Hold |
4,120
| – | – | 0.15% | 173 |
|
|
2019
Q3 | $549K | Hold |
4,120
| – | – | 0.17% | 175 |
|
|
2019
Q2 | $471K | Hold |
4,120
| – | – | 0.15% | 176 |
|
|
2019
Q1 | $511K | Hold |
4,120
| – | – | 0.18% | 149 |
|
|
2018
Q4 | $415K | Hold |
4,120
| – | – | 0.17% | 160 |
|
|
2018
Q3 | $518K | Hold |
4,120
| – | – | 0.17% | 159 |
|
|
2018
Q2 | $455K | Hold |
4,120
| – | – | 0.16% | 171 |
|
|
2018
Q1 | $436K | Buy |
+4,120
| New | +$478K | 0.13% | 202 |
|
Other funds holding ZBH
Atlas Capital Advisors's ZBH Position: Q2 2026 in Review
Atlas Capital Advisors sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 2,910 shares — an estimated $263K sold.
Atlas Capital Advisors first reported a position in ZBH in Q1 2018 and held it in 32 quarters. The position peaked at $1.57M in Q3 2020. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Atlas Capital Advisors reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
- Atlas Capital Advisors sold 2,910 Zimmer Biomet shares in Q2 2026, an estimated $263K.
- Atlas Capital Advisors first reported a position in Zimmer Biomet in Q1 2018 and held it in 32 quarters.
- Atlas Capital Advisors's Zimmer Biomet position peaked at $1.57M in Q3 2020.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.